EXPERIENCE WITH THE USE OF HIGH-DOSE INTERLEUKIN-2 IN THE TREATMENT OF 652 CANCER-PATIENTS

被引：966

作者：

ROSENBERG, SA

LOTZE, MT

YANG, JC

AEBERSOLD, PM

LINEHAN, WM

SEIPP, CA

WHITE, DE

机构：

来源：

关键词：

D O I：

10.1097/00000658-198910000-00008

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

引用

页码：474 / 485

页数：12

共 30 条

[1] CAMERON RB, 1988, CANCER RES, V48, P5810
[2] DUTCHER JP, 1987, P AN M AM SOC CLIN, V6, P246
[3] EISENTHAL A, 1988, CANCER RES, V48, P7140
[4] ETTINGHAUSEN SE, 1985, J IMMUNOL, V135, P1488
[5] IMMUNE INTERVENTIONS IN DISEASE
FAHEY, JL
[J]. ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) : 257 - 274
[6] TUMOR-LOCALIZATION OF ADOPTIVELY TRANSFERRED IN-111 LABELED TUMOR INFILTRATING LYMPHOCYTES IN PATIENTS WITH METASTATIC MELANOMA
FISHER, B
PACKARD, BS
READ, EJ
CARRASQUILLO, JA
CARTER, CS
TOPALIAN, SL
YANG, JC
YOLLES, P
LARSON, SM
ROSENBERG, SA
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (02) : 250 - 261
[7] FISHER RI, 1987, P AN M AM SOC CLIN, V6, P244
[8] TUMOR NECROSIS FACTOR - STILL A PROMISING AGENT
FREI, E
SPRIGGS, D
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (03) : 291 - 294
[9] GEMLO BT, 1988, CANCER RES, V48, P5864
[10] LAFRENIERE R, 1985, J IMMUNOL, V135, P4273